日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeted Delivery of a Potent STING Agonist Payload via an Antibody-Drug Conjugate Drives Robust Antitumor Activity in Preclinical Models

通过抗体-药物偶联物靶向递送强效STING激动剂有效载荷,在临床前模型中展现出强大的抗肿瘤活性

Gruber, David R; Cummins, Elizabeth J; Zeng, Weiping; Ulrich, Michelle; Smith, Kaleb; Long, Mallory; Spahr, Kellie; Higgins, Shaylin; Hinricher, Katelyn; Langalia, Aditi; Krumm, Kora; Olson, Devra J; Grogan, Bryan; Mazahreh, Rebecca; Gupta, Priyanka; Burke, Patrick J; Smith, Alyson; Senter, Peter D; Gardai, Shyra J; Hill, Adam G; Gray, Elizabeth E

Nonfucosylation of an anti-TIGIT antibody enhances FcγR engagement, driving innate immune activation and antitumor activity.

抗TIGIT抗体的非岩藻糖基化增强了FcγR的结合,从而驱动先天免疫激活和抗肿瘤活性

Smith Alyson J, Thurman Robert E, Zeng Weiping, Grogan Bryan, Lucas Sasha, Gutierrez Guadalupe, Heiser Ryan A, Wo Serena W, Blackmarr Amber, Peterson Scott, Gardai Shyra J

Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer

针对 PI3K 和 MAPK 通路改善 HER2 阳性胃癌对 HER2 靶向治疗的反应

M Janusz Mezynski #, Angela M Farrelly #, Mattia Cremona, Aoife Carr, Clare Morgan, Julie Workman, Paul Armstrong, Jennifer McAuley, Stephen Madden, Joanna Fay, Katherine M Sheehan, Elaine W Kay, Ciara Holohan, Yasir Elamin, Shereen Rafee, Patrick G Morris, Oscar Breathnach, Liam Grogan, Bryan T Hen

IL10 and IL10 receptor gene variation and outcomes after unrelated and related hematopoietic cell transplantation

IL10 和 IL10 受体基因变异与无关和相关造血干细胞移植后的预后

Tseng, Li-Hui; Storer, Barry; Petersdorf, Effie; Lin, Ming-Tseh; Chien, Jason W; Grogan, Bryan M; Malkki, Mari; Chen, Pei-Jer; Zhao, Lue P; Martin, Paul J; Hansen, John A